SAL Trading, LLC
CIK
1879635
Location
Wilmington, DE
Portfolio Value
Micro
$57,005,442
Diversification
Highly concentrated
Filing Date
Global Rank
#5,888
/ 7,309
▲ 27
· as of Sep 2024
Top Industry
Drug Manufacturers - General
61.2%
3Y Alpha vs SPY
-8.6%
Period ended 1 year ago
Filed Nov 14, 2024 · 1y
12 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+42.9%
SPY
+76.0%
Annualised alpha
-8.1%
Max drawdown
−22.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
6 positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Top Position
82.4%
−3.2 pts
Top 5
99.1%
+2.2 pts
Top 10
100.0%
0.0 pts
HHI
6,927
Highly concentrated−446
Portfolio Trend
12 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 82.4% | $46,990,370 |
| Healthcare | 14.3% | $8,160,169 |
| Basic Materials | 2.3% | $1,313,358 |
| Energy | 0.9% | $541,545 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
5 positions
6 positions ·
$57,005,442 total
· as of Sep 30, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
Held | 81,899 | $46,990,370 | 82.43% | |
| GSK |
GSK plc
Healthcare
|
NEW | 149,900 | $6,127,912 | 10.75% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 3,749 | $2,032,257 | 3.57% | |
| RIO |
Rio Tinto PLC
Basic Materials
|
Reduced | 11,185 | $796,036 | 1.40% | |
| FRO |
Frontline plc
Energy
|
NEW | 23,700 | $541,545 | 0.95% | |
| MT |
ArcelorMittal
Basic Materials
|
NEW | 19,700 | $517,322 | 0.91% |